SCHEMBL26720293

SCHEMBL26720293

Clc1ccc(-c2nn3c(c2Br)COCC3)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 5/20 0.39
CSNK1D P48730 1/20 0.37
GAA P10253 2/20 0.37
KDM4E B2RXH2 5/20 0.37
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
HTT P42858 1/20 0.36
TSHR P16473 3/20 0.36
ALDH1A1 P00352 2/20 0.36
PHGDH O43175 1/20 0.36
HPGD P15428 1/20 0.36
MGLL Q99685 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPK1 P28482 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
USP2 O75604 2/20 0.35
TRPA1 O75762 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2524313 0.86 CSNK1D (0.48) CSNK1DKDM4ENPC1RAB9ATSHR
SCHEMBL22768040 0.85 ALDH1A1 (0.39) CSNK1DGAAKDM4EHTTTSHR
SCHEMBL26720295 0.82 GRM2 (0.45) CSNK1D
SCHEMBL25220259 0.78 MAPK14 (0.46) CSNK1DKDM4ETSHRALDH1A1HPGD
SCHEMBL26720299 0.73 CYP11B2 (0.40) CSNK1D
SCHEMBL26720231 0.70 CSNK1D (0.57) CSNK1D
SCHEMBL29513172 0.69 CSNK1D (0.67) CSNK1D
SCHEMBL26720817 0.69 CSNK1D (0.67) CSNK1D
SCHEMBL17382679 0.69 CSNK1D (0.48) CSNK1DKDM4ENPC1RAB9ATSHR
SCHEMBL24745361 0.68 LMNA (0.44) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339970-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-20230339970-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
CN-116171280-A Casein kinase 1 delta modulators 詹森药业有限公司 2023-05-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339970-A1 CASEIN KINASE 1 DELTA MODULATORS CSNK1D, CSNK1A1, CSNK1G1 SLC2A1 4271/4885CSNK1D 1/4885GAA 1026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.